Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Legg Mason’s Bill Miller Steps Down, Sam Peters to Manage Fund

Bill Miller, the manager of the Legg Mason Capital Management (LMVTX) mutual fund, announced Thursday that he is stepping down, per Bloomberg.

Bill Miller is Stepping Down from Managing the Legg Mason Fund

Bill Miller, who famously outperformed the S&P 500 for a record 15 years, will no longer be the managing the Legg Mason fund effective April 30. At that point, Sam Peters will take over the management of the Legg Mason Capital Management Value Trust (LMVTX). “April 2012 is the right time for Sam to take over,” Miller said in the statement. “Over the past year, Sam and I made important adjustments to the fund’s portfolio construction and characteristics, and we’re both very pleased with how it is positioned.” Bill Miller will stay on chairman of the Legg Mason Capital Management unit while Peters will take on the role of chief investment officer.

Bill Miller

Sam Peters will Take Over Management of the Legg Mason Fund

Sam Peters joined Legg Mason Capital Management in 2005 after leaving Fidelity Investments where he worked as a stock picker. Last year, Miller announced that Peters would become his co-manager, and eventual successor. Miller himseld had taken over the manangement of the fund in a similar fashion, first co-managing, in his case with Ernie Kiehne, then taking full responsibility. “Bill Miller has been synonymous with Legg Mason for more than 20 years, and Legg Mason’s ability to attract money has been tied to its brand,” said Todd Rosenbluth, a mutual-fund analyst at S&P Capital IQ.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!